Gail M Wilkes1. Show Affiliations » 1. Boston Medical Center, Boston, Massachusetts, USA.
Abstract
Entities: Chemical Disease
Mesh： See more » Angiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/pharmacokineticsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedBevacizumabBrain Neoplasms/drug therapyCarcinoma, Renal Cell/drug therapyGlioblastoma/drug therapyHalf-LifeHumansKidney Neoplasms/drug therapyNeoplasms/drug therapyRandomized Controlled Trials as TopicVascular Endothelial Growth Factor A/metabolism
Substances： See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedVascular Endothelial Growth Factor ABevacizumab
Year: 2009 PMID： 19856612
Source DB: PubMed Journal: Oncology (Williston Park) ISSN： 0890-9091 Impact factor: 2.990